Human cytomegalovirus: clinical aspects, immune regulation, and emerging treatments
Top Cited Papers
- 1 December 2004
- journal article
- review article
- Published by Elsevier in The Lancet Infectious Diseases
- Vol. 4 (12) , 725-738
- https://doi.org/10.1016/s1473-3099(04)01202-2
Abstract
No abstract availableKeywords
This publication has 149 references indexed in Scilit:
- Does cytomegalovirus status influence acute and chronic rejection in heart transplantation during the ganciclovir prophylaxis era?The Journal of Heart and Lung Transplantation, 2003
- Prophylaxis for CMV should not now replace pre‐emptive therapy in solid organ transplantationReviews in Medical Virology, 2001
- Valacyclovir for the Prevention of Cytomegalovirus Disease after Renal TransplantationNew England Journal of Medicine, 1999
- Evaluation by polymerase chain reaction of cytomegalovirus reactivation in intensive care patients under mechanical ventilationIntensive Care Medicine, 1996
- Association between Prior Cytomegalovirus Infection and the Risk of Restenosis after Coronary AtherectomyNew England Journal of Medicine, 1996
- OKT3 Treatment for Allograft Rejection Is a Risk Factor for Cytomegalovirus Disease in Liver TransplantationThe Journal of Infectious Diseases, 1995
- Severe Herpesvirus Infections in an Adolescent without Natural Killer CellsNew England Journal of Medicine, 1989
- Acyclovir for Prevention of Cytomegalovirus Infection and Disease after Allogeneic Marrow TransplantationNew England Journal of Medicine, 1988
- Use of Cytomegalovirus Immune Globulin to Prevent Cytomegalovirus Disease in Renal-Transplant RecipientsNew England Journal of Medicine, 1987
- Cytotoxic T Cells in Cytomegalovirus InfectionNew England Journal of Medicine, 1982